ライフサイエンスコーパス: iron-deficiency anemia

1 Hfe Tg mice exhibited hepcidin excess and iron deficiency anemia.

2 d to elevated hepcidin levels and consequent iron deficiency anemia.

3 in training regimens with iron deficiency or iron deficiency anemia.

4 addition of abnormal hemoglobin to classify iron deficiency anemia.

5 y in children, including iron deficiency and iron deficiency anemia.

6 < 0.05) in volunteers reporting to BCT with iron deficiency anemia.

7 orms causing gastrointestinal blood loss and iron deficiency anemia.

8 sociated with a 40% reduction in the risk of iron deficiency anemia.

9 firm the benefits of successful treatment of iron deficiency anemia.

10 ing cause of gastrointestinal hemorrhage and iron deficiency anemia.

11 tissues, while they continue to have severe iron deficiency anemia.

12 atodes cause gastrointestinal hemorrhage and iron deficiency anemia.

13 an females and significantly associated with iron deficiency anemia.

14 <20 y and education were not associated with iron deficiency anemia.

15 for HFE mutations had a lower prevalence of iron deficiency anemia.

16 reditary hemochromatosis and iron-refractory iron deficiency anemia.

17 (20.5%) were iron deficient; 24 of these had iron deficiency anemia.

18 d finding of thrombocytosis in patients with iron deficiency anemia.

19 240,000 toddlers and 3.3 million women have iron deficiency anemia.

20 rriers have increased hematocrit and risk of iron deficiency anemia.

21 with non-dialysis chronic kidney disease and iron deficiency anemia.

22 roved micronutrient intakes and reduction in iron deficiency anemia.

23 eople worldwide whose inadequate diet causes iron deficiency anemia.

24 12 months of age in infants at high risk for iron deficiency anemia.

25 e to be a safe and efficacious treatment for iron deficiency anemia.

26 PRSS6, whose mutations cause iron refractory iron deficiency anemia.

27 ation of iron in macrophages and symptoms of iron deficiency anemia.

28 t challenge the entrenched oral treatment of iron deficiency anemia.

29 he United States who do not have symptoms of iron deficiency anemia.

30 l disorders had been treated for concomitant iron deficiency anemia.

31 nmol/L; P<0.05) and low in one patient with iron deficiency anemia.

32 n and appeared to be effective in correcting iron deficiency anemia.

33 s and underlies erythropoietic repression in iron deficiency anemia.

34 His blood count shows signs of mild iron deficiency anemia.

35 distinguishes thalassemia-trait anemia from iron-deficiency anemia.

36 rriers, 20%, p = 4e-7, OR = 5), particularly iron-deficiency anemia.

37 following: osteoporosis or low bone mass or iron-deficiency anemia.

38 ced the risk of anemia, iron deficiency, and iron-deficiency anemia.

39 either patients with rheumatoid arthritis or iron-deficiency anemia.

40 eficiency progresses from low iron stores to iron-deficiency anemia.

41 deficiency without anemia and about 13% have iron-deficiency anemia.

42 is, and it predisposes Tfrc(Alb-Cre) mice to iron-deficiency anemia.

43 rrection in a mouse model of iron-refractory iron-deficiency anemia.

44 al cancer mortality/morbidity and changes to iron-deficiency anemia.

45 ted patients with unexplained, mild, chronic iron-deficiency anemia.

46 be considered for children with nutritional iron-deficiency anemia.

47 reditary hemochromatosis and iron-refractory iron-deficiency anemia.

48 ally important biomarker in diseases such as iron-deficiency anemia.

49 e score), and laboratory tests suggestive of iron deficiency anemia (0.5-percentage point reduction [

50 followed by essential hypertension (4%) and iron deficiency anemia (3%).

51 men [34.7%] vs 225 women [13.6%]; P < .001), iron deficiency anemia (347 women [21.0%] vs 135 women [

52 mia, 6 with secondary erythrocytosis, 2 with iron-deficiency anemia, 4 with hemochromatosis, or 5 nor

53 practical improvements in the management of iron deficiency anemia, a disorder that may affect as ma

54 Consuming wildmeat may protect against iron-deficiency anemia, a serious public health problem

55 riations in predictors of iron deficiency or iron deficiency anemia according to iron supplementation

56 gh-intensity infection had a greater risk of iron deficiency anemia (adjusted prevalence odds ratio:

57 Iron deficiency anemia affects >1.2 billions individuals

58 Iron deficiency anemia afflicts 1 in 3 individuals, most

59 Nontransgenic mice with acquired iron deficiency anemia also show thrombocytosis and Mk-b

60 tor development, risk of iron deficiency, or iron deficiency anemia among breastfed infants in a sett

61 The odds of iron deficiency anemia among children aged 12-15 y were

62 need for successful interventions to reduce iron deficiency anemia among food-insecure children and

63 ecause of the tendency of infants to develop iron deficiency anemia and because of the documented adv

64 objective was to estimate the prevalence of iron deficiency anemia and examine potential reasons for

65 n models were used to identify predictors of iron deficiency anemia and iron deficiency without anemi

66 estigation of the potential contributions of iron deficiency anemia and iron treatment to this differ

67 Hookworm infection is a major cause of iron deficiency anemia and malnutrition in developing co

68 In this cohort study of 24 patients with iron deficiency anemia and severe aortic stenosis, angio

69 6 knockout (Tmprss6-/-) mice, which exhibit iron deficiency anemia and thrombocytosis, we observed a

70 to his gastroenterologist for evaluation of iron deficiency anemia and weight loss.

71 Both children were diagnosed with iron deficiency anemia and were suspected to have an ass

72 nical study compared 96 female patients with iron-deficiency anemia and 60 healthy female control sub

73 or further evaluation, from which those with iron-deficiency anemia and active bleeding had been excl

74 l manifestation is epistaxis that results in iron-deficiency anemia and reduced health-related qualit

75 nes the association of lice infestation with iron-deficiency anemia and risk factors such as homeless

76 d controlled trial focusing on patients with iron deficiency (+ /- anemia) and ND-CKD (serum ferritin

77 gastrointestinal blood loss, and unexplained iron-deficiency anemia), and the performance of selected

78 Fifty-two percent of the subjects had iron deficiency anemia, and 30% had serum 25-hydroxyvita

79 Twenty-five percent of all anemia, 35% of iron deficiency anemia, and 73% of severe anemia were at

80 cantly lower prevalences of iron deficiency, iron deficiency anemia, and low vitamin B-12 and, in Ken

81 , and 12.1% of children had low iron stores, iron deficiency anemia, and VA deficiency, respectively.

82 ity of iron fortification of food to improve iron deficiency, anemia, and biological outcomes is not

83 hepcidin regulated intestinal HIF-2alpha in iron deficiency, anemia, and iron overload.

84 in A stores and decreasing the prevalence of iron deficiency, anemia, and vitamin A deficiency.

85 upus erythematosus; infections; splenectomy; iron deficiency anemia; and solid tumors such as lung ca

86 ong-standing type II diabetes, hypertension, iron deficiency anemia, aortic stenosis, and prior baria

87 ng enteropathy being a consequence of severe iron deficiency anemia are discussed.

88 Pediatrics recommendations for prevention of iron deficiency anemia are reviewed.

89 Iron deficiency and iron deficiency anemia are still relatively common in to

90 Poor iron status and iron deficiency anemia are the hallmarks of hookworm dis

91 Iron deficiency and iron-deficiency anemia are common conditions that may ca

92 a defect in iron absorption that results in iron-deficiency anemia, as revealed by an N-ethyl-N-nitr

93 nt deficiency among children worldwide, with iron-deficiency anemia associated with long-term adverse

94 age and ferritin level, iron deficiency, and iron deficiency anemia at 8 and 12 months of age.

95 s associated with decreased risk of maternal iron deficiency anemia at term (4 trials, n = 2230; 8.6%

96 rum ferritin levels and a lower incidence of iron-deficiency anemia at 4-6 months of age.

97 h outcomes that are associated with maternal iron deficiency anemia, both Canada and the United State

98 ytol is approved for use in the treatment of iron deficiency anemia, but it can serve as an alternati

99 Intravenous iron enables rapid correction of iron-deficiency anemia, but certain formulations induce

100 One infant developed iron deficiency anemia by 5.5 mo of age.

101 RR, 0.48; 95% CI, 0.32-0.70) and the risk of iron deficiency anemia by 66% (RR, 0.34; 95% CI, 0.19-0.

102 However, in some CD patients, iron deficiency anemia can be persistent despite a GFD.

103 e anemia of chronic disease, iron refractory iron deficiency anemia, cancer, hereditary hemochromatos

104 theless, studies of a murine iron-refractory iron-deficiency anemia-causing mutant (Mt2I286F) in the

105 Four of 8 of the deprived monkeys had iron deficiency anemia compared with none of the control

106 of anemia; and had a 64% lower prevalence of iron-deficiency anemia compared with control group child

107 Iron-deficiency anemia, defined as low hemoglobin due to

108 R: 0.6; CI: 0.4, 0.7), but the prevalence of iron deficiency anemia did not change significantly in c

109 (mk) mice and Belgrade (b) rats have severe iron deficiency anemia due to defects in intestinal iron

110 She had a history of iron-deficiency anemia due to long-standing celiac disea

111 reduces the incidence of iron deficiency and iron deficiency anemia during pregnancy, but evidence on

112 of routine screening and supplementation for iron deficiency anemia during pregnancy.

113 s addressed screening for iron deficiency or iron deficiency anemia during pregnancy.

114 or harms of screening for iron deficiency or iron deficiency anemia during pregnancy.

115 ilar for both groups and no infant developed iron deficiency anemia during the trial.

116 dered iron metabolism, leading to functional iron deficiency, anemia, erythropoietic protoporphyria,

117 ns were undetectable or low in patients with iron deficiency anemia (ferritin < 10 ng/mL), iron-deple

118 hildren aged 9 to 48 months with nutritional iron-deficiency anemia, ferrous sulfate compared with ir

119 uction and its great value in distinguishing iron deficiency anemia from the anemia of chronic diseas

120 lavin deficiency (from 60% to 6%; P<0.0001), iron deficiency anemia (from 35% to 15%; P<0.007), and a

121 Patients with iron-deficiency anemia had a significantly reduced choro

122 F3B1-wildtype MDS, megaloblastic anemia, and iron deficiency anemia), Haemorasis detected over half a

123 India's high prevalence of iron-deficiency anemia has largely been attributed to th

124 8, 245 patients aged 18 years and older with iron-deficiency anemia (hemoglobin level <=11 g/dL; seru

125 roke (HR per 1 SD, 0.85; 95% CI, 0.76-0.95), iron deficiency anemia (HR per 1 SD, 0.91; 95% CI, 0.84-

126 reveal that genetic variants associated with iron deficiency anemia (ICD10), obesity, type 2 diabetes

127 Iron deficiency anemia (IDA) affects 50 % to 60 % of Ind

128 e aims are to investigate the association of iron deficiency anemia (IDA) and FM and to find the effe

129 alysis was to assess the association between iron deficiency anemia (IDA) and retinal changes via opt

130 n Southeast Asia, Thalassemia trait (TT) and iron deficiency anemia (IDA) are the two most common ane

131 Although the hazards associated with iron deficiency anemia (IDA) are well known, concerns ab

132 The effects of infantile iron deficiency anemia (IDA) extend beyond hematological

133 Iron deficiency anemia (IDA) has detrimental effects on

134 tinal workup fails to establish the cause of iron deficiency anemia (IDA) in a substantial proportion

135 Routine screening and supplementation for iron deficiency anemia (IDA) in asymptomatic, nonanemic

136 The actual prevalence of anemia, ID, and iron deficiency anemia (IDA) in California remains uncle

137 on between Helicobacter pylori infection and iron deficiency anemia (IDA) in humans.

138 gastritis-induced achlorhydria is a cause of iron deficiency anemia (IDA) in humans.

139 d as the standard approach for investigating iron deficiency anemia (IDA) in men older than 45 and po

140 alues in anemia of chronic disease (ACD) and iron deficiency anemia (IDA) in patients with RA.

141 The prevalence of iron deficiency anemia (IDA) increased over the malaria

142 Iron deficiency anemia (IDA) is a major public health co

143 When detected early in pregnancy, iron deficiency anemia (IDA) is associated with a > 2-fo

144 Recognition of iron deficiency anemia (IDA) is important to initiate ti

145 Iron deficiency anemia (IDA) is relatively common in the

146 Preoperative iron deficiency anemia (IDA) occurs frequently; however

147 Iron deficiency anemia (IDA) still remains universally p

148 The prevalence of iron deficiency (ID) and iron deficiency anemia (IDA) was 10-32% and 2-5%, respec

149 ntation strategy is unclear in patients with iron deficiency anemia (IDA) who have either normal kidn

150 than 1 billion people worldwide suffer from iron deficiency anemia (IDA), a state of systemic iron i

151 uate the prevalence of iron deficiency (ID), iron deficiency anemia (IDA), and other measures of iron

152 based on iron biomarker concentrations were iron deficiency anemia (IDA), anemia of inflammation (AI

153 nemia at delivery, and 25% (n = 5) developed iron deficiency anemia (IDA).

154 and about half of this burden is a result of iron deficiency anemia (IDA).

155 ency (plasma ferritin < 12 ug/L) by 56%, and iron deficiency anemia (IDA; Hb < 110 g/L and plasma fer

156 deficiency (ID; diminished iron stores) and iron deficiency anemia (IDA; poor iron stores and dimini

157 Iron-deficiency anemia (IDA) affects millions of persons

158 c endoscopy or colonoscopy among adults with iron-deficiency anemia (IDA) and/or hematochezia have no

159 itional biomarkers used for the diagnosis of iron-deficiency anemia (IDA) in patients with CKD have l

160 ction is associated with iron deficiency and iron-deficiency anemia (IDA) in the United States.

161 ts and young children in Sub-Saharan Africa, iron-deficiency anemia (IDA) is common, and many complem

162 nemia was defined as hemoglobin < 11 g/d and iron-deficiency anemia (IDA) was defined as low ferritin

163 ferritin, which was suitable for identifying iron-deficiency anemia (IDA), but less reliable than ser

164 of severe complications that may arise from iron deficiency anemia if it is not recognized and treat

165 eraction at the locus, impacting the risk of iron deficiency anemia in African Americans with specifi

166 The treatment of iron deficiency anemia in children with inflammatory bow

167 e strongest predictor of iron deficiency and iron deficiency anemia in children.

168 n a diagnostic panel for iron deficiency and iron deficiency anemia in children.

169 ng the beneficial impact of WIC revisions on iron deficiency anemia in children.

170 nfection is associated with growth delay and iron deficiency anemia in developing countries.

171 preventing and treating iron deficiency and iron deficiency anemia in infants and young children.

172 Intravenous iron is commonly used to treat iron deficiency anemia in non-dialysis chronic kidney di

173 riate for determining hemoglobin cutoffs for iron deficiency anemia in other populations.

174 n may offer a new, efficient option to treat iron deficiency anemia in patients with CKD.

175 appropriate for estimating the prevalence of iron deficiency anemia in poor Jamaican girls 13-14 y of

176 Current knowledge indicates that iron deficiency anemia in pregnancy is a risk factor for

177 for pregnant women or routine screening for iron deficiency anemia in pregnant women or young childr

178 lance of benefits and harms of screening for iron deficiency anemia in pregnant women to prevent adve

179 nematodes, are currently a leading cause of iron deficiency anemia in the developing world.

180 o estimate prevalence of iron deficiency and iron deficiency anemia in the Jamaican girls: 7.6% and 4

181 the prostate 3 (Steap3), responsible for the iron deficiency anemia in the mouse mutant nm1054.

182 ption and iron overload, iron deficiency, or iron deficiency anemia in the U.S. population.

183 kworm disease is among the leading causes of iron-deficiency anemia in the developing world and is as

184 prevalences of anemia, iron deficiency, and iron deficiency anemia increased in all three trial grou

185 e serine protease mutated in iron-refractory iron deficiency anemia, inhibits hepcidin expression by

186 the familial anemia disorder iron-refractory iron deficiency anemia (IRIDA).

187 Iron-refractory, iron-deficiency anemia (IRIDA) is a familial disorder ch

188 n deficiency (serum ferritin <12 ng/mL), and iron deficiency anemia (iron deficiency and hemoglobin <

189 In particular, iron deficiency anemia is a major global health issue, b

190 Iron deficiency anemia is common and consequential in no

191 The prevalence of iron deficiency anemia is likely to be higher in athleti

192 The prevalence of iron deficiency anemia is low (3%) among unsupplemented

193 Iron deficiency anemia is one of the most serious forms

194 Globally, iron deficiency anemia is the most common cause of anemi

195 Although iron deficiency anemia is the most common human nutritio

196 Our results may explain why iron deficiency anemia is the most pronounced early mani

197 ren in low and middle income countries where iron-deficiency anemia is highly prevalent.

198 al cancer, and 6 to 13 percentage points for iron deficiency anemia laboratory tests suggestive of co

199 oferrone, iron-restricted erythropoiesis) or iron deficiency anemia (low hepcidin).

200 Vitamin B-12 deficiency, iron-deficiency anemia, low ferritin, and low HDL were m

201 e only significant multivariate predictor of iron deficiency anemia (LRT = 30.43; P<.001).

202 eed on blood in the small intestine, causing iron-deficiency anemia, malnutrition, growth and develop

203 nolytic therapy, antiangiogenic therapy, and iron deficiency anemia management across the HHT disease

204 ndividuals with nonanemic iron deficiency or iron-deficiency anemia may be asymptomatic or experience

205 m faster (P = 0.038) than did the women with iron deficiency anemia (n = 34).

206 oglobin level, iron-deficiency (IDA) and non-iron-deficiency anemia (NIDA), and inflammatory markers.

207 Summary statistics on iron deficiency anemia, night blindness, and risk of zin

208 decreasing risk of traits related to anemia (iron deficiency anemia: odds ratio [OR] scaled to a stan

209 e, single-center cohort study, patients with iron deficiency anemia on the TAVI waiting list from Sep

210 Patients with documented iron-deficiency anemia or active gastrointestinal bleedi

211 women who are malnourished, have symptoms of iron deficiency anemia, or have special hematologic cond

212 The other major modes of presentation are iron-deficiency anemia, osteoporosis, screening of famil

213 risk of SGA birth was lower in subjects with iron deficiency anemia (P = 0.002).

214 during early development in iron-refractory iron deficiency anemia patients, who present with microc

215 e, did not improve iron status or rescue the iron deficiency anemia phenotype.

216 duodenal enterocytes, resulting in a severe iron deficiency anemia phenotype.

217 failed to improve iron status or rescue the iron deficiency anemia phenotype.

218 ating our findings from the murine models of iron deficiency anemia, primary human MEPs exhibit decre

219 Here, we show that iron deficiency anemia refractory to oral iron therapy c

220 s underlying thrombocytosis in patients with iron deficiency anemia remain unknown.

221 Although much of the ethnic disparity in iron deficiency anemia remains unexplained, factors asso

222 ve risk [RR], 0.46; 95% CI, 0.16 to 1.30) or iron deficiency anemia (RR, 0.78; 95% CI, 0.05 to 12.46)

223 black woman has heavy menstrual bleeding and iron-deficiency anemia.She reports nocturia and urinary

224 ntually the microcytic hypochromic anemia or iron deficiency anemia that is the clinical hallmark of

225 ts in substantial psychosocial morbidity and iron deficiency anemia that may be severe.

226 ion but diagnosis and management of absolute iron deficiency anemia, the anemia of inflammation with

227 the most effective therapy of IBD-associated iron deficiency anemia, the perception of risk related t

228 thickness (CT) in the eyes of patients with iron-deficiency anemia, the most common form of the anem

229 boratory evaluation was notable for profound iron deficiency anemia, thrombocytosis, and hyperhomocys

230 nd clinical trial in adults with NDD-CKD and iron deficiency anemia to compare the safety and efficac

231 pcidin levels for diagnosing iron-refractory iron deficiency anemia to global health applications suc

232 f iron status across the full continuum from iron deficiency anemia to iron deficiency to iron replet

233 ore whole-grain products, but would increase iron-deficiency anemia to 5.0% (95% CI: 3.9%, 6.4%).

234 common symptoms of irritable bowel syndrome, iron deficiency anemia, unexplained arthritis, and even

235 IDA) is a familial disorder characterized by iron deficiency anemia unresponsive to oral iron treatme

236 , and iron supplement use, the prevalence of iron deficiency anemia was 2.3 times higher in Mexican A

237 old income) >3.0, however, the prevalence of iron deficiency anemia was 2.6 +/- 0.9% in Mexican Ameri

238 The prevalence of iron deficiency anemia was 31% in the NI control group c

239 The prevalence of iron deficiency anemia was 6.2 +/- 0.8% (f1.gif" BORDER=

240 Iron deficiency anemia was defined as abnormal results f

241 Iron deficiency anemia was defined as the presence of bo

242 ldbearing age were iron deficient; of these, iron deficiency anemia was found in 3% and 2% to 5%, res

243 e strongest) predictor of iron deficiency or iron deficiency anemia was lower 6-mo hemoglobin.

244 The prevalence of iron deficiency anemia was lower in women who carried HF

245 Post administration of FCM, correction of iron deficiency anemia was observed with improved mean h

246 Iron-deficiency anemia was the top cause globally, altho

247 ytopenia, sustained neutropenia, anemia, and iron deficiency anemia were infrequent and similar acros

248 alence rates of anemia, iron deficiency, and iron deficiency anemia were significantly lower after 24

249 The best-studied example is iron deficiency anemia, which increases intestinal iron

250 1%, 32.7%) to 6.8% (95% CI: 4.2%, 9.3%), and iron deficiency anemia, which was 6.2% (95% CI: 3.0%, 9.

251 In 2 randomized trials of patients with iron-deficiency anemia who were intolerant of or unrespo

252 uch that newborn homozygous Pcm mice exhibit iron deficiency anemia with increased duodenal Fpn1 expr

253 NHANES III classified iron-deficiency anemia with other nutritional anemias, a

254 ckout mice (characterized by iron-refractory iron deficiency anemia) with and without adenine diet-in

255 ted with reduced risk of iron deficiency and iron deficiency anemia without a concomitant increase in